Editorial Commentary
Precision infliximab rescue in acute severe ulcerative colitis
Translational Gastroenterology and Hepatology
2026;
11:
125
.
(30 September 2026)
Editorial Commentary
Digital cognitive behavioural self-management programme for fatigue, pain, urgency and incontinence in inflammatory bowel disease
Translational Gastroenterology and Hepatology
2026;
11:
124
.
(30 September 2026)
Editorial Commentary
Tobevibart plus elebsiran for the treatment of hepatitis D: how should we read the phase 2 data?
Translational Gastroenterology and Hepatology
2026;
11:
123
.
(30 September 2026)
Editorial Commentary
The appendix and ulcerative colitis: from an unsolved connection to a therapeutic strategy
Translational Gastroenterology and Hepatology
2026;
11:
122
.
(30 September 2026)
Editorial Commentary
PREDICT-UC, infliximab pharmacokinetics, and the pursuit of personalised rescue therapy in acute severe ulcerative colitis
Translational Gastroenterology and Hepatology
2026;
11:
121
.
(30 September 2026)
Editorial Commentary
Silencing apolipoprotein C-III to silence pancreatitis: olezarsen and the maturation of RNA-targeted therapy for severe hypertriglyceridemia
Translational Gastroenterology and Hepatology
2026;
11:
120
.
(30 September 2026)
Editorial Commentary
What did the prospective validation of the Pancreatic Fistula Risk Classification by the International Study Group for Pancreatic Surgery (PARIS) trial tell us?
Translational Gastroenterology and Hepatology
2026;
11:
119
.
(30 September 2026)
Editorial Commentary
Tobevibart plus elebsiran in hepatitis D: crossing a therapeutic threshold
Translational Gastroenterology and Hepatology
2026;
11:
118
.
(30 September 2026)
Editorial Commentary
Reconsidering therapeutic strategies after biologic failure in ulcerative colitis: appendectomy versus Janus kinase inhibition
Translational Gastroenterology and Hepatology
2026;
11:
117
.
(30 September 2026)
Editorial Commentary
Not whether, but for whom: EUS-guided choledochoduodenostomy and the prevention of post-procedural pancreatitis in malignant distal biliary obstruction
Translational Gastroenterology and Hepatology
2026;
11:
116
.
(30 September 2026)
Review Article
Progress of machine perfusion in managing donor-derived infections in liver transplantation
Translational Gastroenterology and Hepatology
2026;
11:
115
.
(30 September 2026)
Review Article
Artificial intelligence in colonoscopy for colorectal cancer prevention: a comprehensive narrative review of technology, evidence and clinical implementation
Translational Gastroenterology and Hepatology
2026;
11:
114
.
(30 September 2026)
Review Article
The overlooked surface: cutaneous manifestations of inflammatory bowel disease
Translational Gastroenterology and Hepatology
2026;
11:
113
.
(30 September 2026)
Review Article
A narrative review of sex-related differences in inflammatory bowel disease-associated cardiovascular and thrombotic risk: epidemiology, mechanisms, and prevention strategies
Translational Gastroenterology and Hepatology
2026;
11:
112
.
(30 September 2026)
Review Article
Gut microbiota profile and response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review
Translational Gastroenterology and Hepatology
2026;
11:
111
.
(30 September 2026)
Review Article
Mechanistic investigation of the crosstalk between hepatic ischemia-reperfusion injury and intestinal microbiota
Translational Gastroenterology and Hepatology
2026;
11:
110
.
(30 September 2026)
Case Series
Non-exposure omental sealing endoscopic full-thickness resection (NEOS-EFTR) with sentinel node navigation surgery for early gastric cancer: a case series
Translational Gastroenterology and Hepatology
2026;
11:
109
.
(30 September 2026)
Brief Report
Gastroparesis in heart failure: temporal trends, clinical correlates, and outcomes in a large national cohort
Translational Gastroenterology and Hepatology
2026;
11:
108
.
(30 September 2026)
Original Article
Postoperative course of C-reactive protein level after liver surgery—when to worry?
Translational Gastroenterology and Hepatology
2026;
11:
107
.
(30 September 2026)
Original Article
Prognostic value of IκB kinase-interacting protein (IKBIP) in stomach adenocarcinoma
Translational Gastroenterology and Hepatology
2026;
11:
106
.
(30 September 2026)
Original Article
Laparoscopic vs. open second hepatectomy for recurrent hepatocellular carcinoma: a propensity score matching analysis of Takasaki’s Glissonean pedicle approach
Translational Gastroenterology and Hepatology
2026;
11:
105
.
(30 September 2026)
Original Article
Predictive target of portal pressure reduction and clinical significance of the PVT subgroup for hepatic encephalopathy after TIPS in decompensated cirrhosis
Translational Gastroenterology and Hepatology
2026;
11:
104
.
(30 September 2026)
Original Article
Neutrophil-to-lymphocyte ratio and reversal of decompensation in primary biliary cholangitis: a retrospective cohort study
Translational Gastroenterology and Hepatology
2026;
11:
103
.
(30 September 2026)
Original Article
Modified laparoscopic Toupet fundoplication with vagus nerve sparing via total left-side approach for hiatal hernia with gastroesophageal reflux disease: a pilot study
Translational Gastroenterology and Hepatology
2026;
11:
102
.
(30 September 2026)
Original Article
A mechanism-derived four-gene prognostic signature for hepatocellular carcinoma based on the multi-target anti-tumor activity of icaritin
Translational Gastroenterology and Hepatology
2026;
11:
101
.
(30 September 2026)
Original Article
Preoperative portal vein thrombosis did not compromise long-term survival after liver transplantation with proper portal inflow reconstruction
Translational Gastroenterology and Hepatology
2026;
11:
100
.
(30 September 2026)
Original Article
Fedratinib treatment correlates with suppressed STAT3/AKT/calpain-1 signaling and inhibits hepatocellular carcinoma progression
Translational Gastroenterology and Hepatology
2026;
11:
99
.
(30 September 2026)
Original Article
Exploratory analysis of serum FGF-21 and CK-18 as biomarkers for ultrasound-detected MASLD in type 2 diabetes mellitus: a UAE multicenter study
Translational Gastroenterology and Hepatology
2026;
11:
98
.
(30 September 2026)
Original Article
Integrated bioinformatics analysis of prognostic significance and molecular regulation of mitochondrial metabolism-related genes in colorectal cancer
Translational Gastroenterology and Hepatology
2026;
11:
97
.
(30 September 2026)
Original Article
Clinical and laboratory characteristics associated with ascites in patients with MASLD-related cirrhosis: a cross-sectional study
Translational Gastroenterology and Hepatology
2026;
11:
96
.
(30 September 2026)
Expert Consensus
Aligning policy and clinical guidelines for albumin use in cirrhosis: insights from Indonesia Hepatology Medical Workgroup Meeting
Translational Gastroenterology and Hepatology
2026;
11:
95
.
(30 September 2026)
Review Article
Optimizing detection and resection of colorectal polyps
Translational Gastroenterology and Hepatology
2026;
11:
94
.
(30 July 2026)
Review Article
Liver reprogramming toward hepatocellular carcinoma following hepatitis C sustained virologic response: a narrative review
Translational Gastroenterology and Hepatology
2026;
11:
93
.
(30 July 2026)
Review Article
Secondary sclerosing cholangitis: contemporary etiologies, diagnostic pathways, and treatment strategies for clinicians: a narrative review
Translational Gastroenterology and Hepatology
2026;
11:
92
.
(30 July 2026)
Review Article
Noninvasive multimodal management of portal hypertension: from early screening to precision clinical decision-making
Translational Gastroenterology and Hepatology
2026;
11:
91
.
(30 July 2026)
Original Article
Efficacy and safety of endoscopic transcecal appendectomy: a systematic review and meta-analysis
Translational Gastroenterology and Hepatology
2026;
11:
90
.
(30 July 2026)
Original Article
Dynamic feedback between IL-6 and TWIST1 drives pancreatic cancer progression
Translational Gastroenterology and Hepatology
2026;
11:
89
.
(30 July 2026)
Original Article
Assessing variability in predictors of adequate follow-up after esophageal food bolus impaction: a retrospective study and literature review
Translational Gastroenterology and Hepatology
2026;
11:
88
.
(30 July 2026)
Original Article
A six-gene prognostic signature for aflatoxin B1-associated hepatocellular carcinoma identified through integrated bioinformatics and network toxicology
Translational Gastroenterology and Hepatology
2026;
11:
87
.
(30 July 2026)
Original Article
Global research trends on the gut microbiota and immunotherapy for colorectal cancer: a bibliometric analysis
Translational Gastroenterology and Hepatology
2026;
11:
86
.
(30 July 2026)
Editorial Commentary
From detection to ruling out in pancreatic cancer: a new perspective
Translational Gastroenterology and Hepatology
2026;
11:
85
.
(30 July 2026)
Editorial Commentary
Exploring the role of immunotherapy and radiotherapy in the adjuvant landscape of resected pancreatic cancer
Translational Gastroenterology and Hepatology
2026;
11:
84
.
(30 July 2026)
Editorial Commentary
Current challenges in screening for pancreatic ductal adenocarcinoma: an appraisal of the METAPAC study
Translational Gastroenterology and Hepatology
2026;
11:
83
.
(30 July 2026)
Editorial Commentary
Early infliximab levels and clearance predict outcomes in acute severe ulcerative colitis
Translational Gastroenterology and Hepatology
2026;
11:
82
.
(30 July 2026)
Editorial Commentary
Reframing pancreatic cancer diagnosis: metabolic signatures and the challenge of rule-out testing
Translational Gastroenterology and Hepatology
2026;
11:
81
.
(30 July 2026)
Editorial Commentary
Intermittent inflow occlusion during robotic donor hepatectomy: technical refinement in a high-stakes operation through a randomized controlled trial
Translational Gastroenterology and Hepatology
2026;
11:
80
.
(30 July 2026)
Editorial Commentary
An itch finally addressed: linerixibat and the promise of targeted antipruritic therapy in primary biliary cholangitis
Translational Gastroenterology and Hepatology
2026;
11:
79
.
(30 July 2026)
Editorial Commentary
Catching pancreatic cancer early: the promise of affordable biomarkers to regularly screen high-risk individuals
Translational Gastroenterology and Hepatology
2026;
11:
78
.
(30 July 2026)
Editorial Commentary
Adjuvant multimodality immunotherapy in resected high-risk pancreatic ductal adenocarcinoma
Translational Gastroenterology and Hepatology
2026;
11:
77
.
(30 July 2026)
Editorial Commentary
Robotic right living donor hepatectomy with intermittent inflow occlusion: true clinical benefit or just another chapter in the ischemic preconditioning story?
Translational Gastroenterology and Hepatology
2026;
11:
76
.
(30 July 2026)
